At the last check on Friday, CME Group Inc.’s (NASDAQ:CME) stock was up $4.18, moving up 2.06 percent to $207.02. The average number of shares traded per day over the past five days has been 1,195,493 shares. 5 times new highs have been achieved over the past 5 days, with a $6.82 gain in that time frame. In the last twenty days, the average volume was 1,419,703, while in the previous 50 days, it was 1,593,671.
Since last month, CME stock rose 12.97%. Shares of the company fell to $180.11 on 07/12/23, the lowest level in the past month. A 52-week high of $203.81 was reached on 08/04/23 after having rallying from a 52-week low of $162.26. Since the beginning of this year, CME’s stock price has risen by 23.11% or $38.07, and marked a new high 18 times. However, the stock has increased by 1.58% since its 52-week high.
CME stock investors should be aware that CME Group Inc. (CME) stock had its last reported insider trading activity 7 days ago on Jul 28. Cutinho Sunil, the Chief Information Officer of the company, disposed of 9,328 shares for $198.66 on Jul 28. It resulted in a $1,853,100 divestment by the insider. Cutinho Sunil sold 10,102 shares at an average price of $198.68 on Jul 27. The insider now owns 32,534 shares following the transaction. On Jun 27, Director SHEPARD WILLIAM R bought 309 shares at $179.77 apiece. The transaction was valued at $55,523.
Valuation Metrics
Right now, CME Group Inc. (CME) has a P/E ratio of about 25.29. The stock’s beta is 0.42. Besides these, the trailing price-to-sales (P/S) ratio of 7.42, the price-to-book (PB) ratio of 2.71, and the price-to-cash flow ratio of 222.91 may also be considered.
The latest dividend of $1.10 per share was paid out, remained unchanged from last year’s $1.10.
Financial Health
In the three months ended June 29, CME Group Inc.’s quick ratio stood at 1.00, while its current ratio was 1.00, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.13, and the total debt-to-equity ratio was 0.13. In the year ended June 29, operating margins totaled 52.10%. Based on annual data, CME earned $2.0 billion in gross profit and brought in $5.02 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 14.50%. Return on equity (ROE) for the past 12 months was 9.60%.
In CME Group Inc.’s quarter-end financial report for June 29, it reported total debt of $3.42 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. CME’s revenue rose 9.04% to $1.44 billion during the quarter, while net income inched up to $1.36 billion. While analysts expected CME Group Inc. to report $2.2 quarterly earnings, the actual figure was $2.3 per share, beating the consensus estimate by 4.50%. During the quarter, the company generated $927.9 million in EBITDA. The liabilities of CME Group Inc. were 123.48 billion at the end of its most recent quarter ended June 29, and its total debt was $3.91 billion. The value of shareholders’ equity is $359.75 million.
Technical Picture
This quick technical analysis looks at CME Group Inc.’s (CME) price momentum. With a historical volatility rate of 18.57%, the RSI 9-day stood at 89.25% on 03 August.
With respect to its five-day moving average, the current CME Group Inc. price is up by +3.42% percent or $6.82. At present, CME shares trade +13.35% above its 20-day simple moving average and +14.76% percent above its 100-day simple moving average. However, the stock is currently trading approximately +15.16% above its SMA50 and +18.42% above its SMA200.
Stochastic coefficient K was 91.55% and Stochastic coefficient D was 89.51%, while ATR was 3.34. Given the Stochastic reading of 90.92% for the 14-day period, the RSI (14) reading has been calculated as 82.22%. As of today, the MACD Oscillator reading stands at 3.41, while the 14-day reading stands at 7.43.
Analyst Ratings
Barclays launched its rating on CME Group Inc. (NASDAQ: CME) to an Overweight in a note to investors on June 28, 2023. CME Group Inc. (CME) has been rated Overweight by analysts. According to 2 brokerage firms, CME is a sell, and 6 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 3 analysts rate CME Group Inc. stock as buy, with 8 recommending it as overweight.
With a median target price of $216.50, the current consensus forecast for the stock is $155.00 – $254.00. Based on these forecasts, analysts predict CME Group Inc. (CME) will achieve an average price target of $209.69.
